Figure 5
Elevated levels of inflammatory cytokines in individuals with pancreatic duct adenocarcinoma. PGE2 levels in plasma from pancreatic duct adenocarcinoma (PDAC), none resectable pancreatic tumor (NRPT), billary duct adenocarcinoma (BDAC), ampullary carcinoma (AC), endocrine carcinoma (EC), and chronic pancreatitis (CP) pre (A) and post (B) tumor resection compared to levels in healthy age matched controls. CXCL8 levels in plasma from PDAC, NRPT, BDAC, AC, EC, and CP pre (C) and post (D) tumor resection compared to levels in healthy age matched controls. CXCL8 levels in plasma from PDAC pre and post (E) tumor resection compared to levels in healthy age matched controls. Statistically significant differences between individuals with pancreatic disease and healthy controls are indicated as; * = p < 0.05, ** = p < 0.005, *** = p < 0.001.